IP Library Granted Patent US 9,526,770
Granted Patent B2
US 9,526,770 · App. 14/004,992 · Granted Dec 27, 2016

Methods of modulating bone remodeling

Inventors: Scheffer Tseng (Pinecrest, FL); Ek Kia Tan (Miami, FL); Hua He (Miami, FL)
Assignee: TISSUETECH, INC.
A61K38/57A61K35/50A61K35/51A61K35/54A61L27/26A61L27/34A61L27/3604A61L27/54A61L2300/236A61L2300/252A61L2300/434A61L2300/45A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,770
App. No.
14/004,992
Granted
Dec 27, 2016
Kind
B2
Abstract

Disclosed herein, in certain instances, are methods of inhibiting osteoclast differentiation, bone resorption, bone formation, and bone remodeling in an individual in need thereof, comprising administering to the individual a composition comprising substantially fetal support tissue product including amniotic membrane and umbilical cord or an extract thereof, or a composition comprising substantially isolated HC-HA complex.

Claims (11)

1. A method of inhibiting unwanted bone resorption in an individual in need thereof, comprising contacting a bone or joint characterized by unwanted bone resorption in said individual with a therapeutically-effective amount of a fetal support tissue that comprises: (a) cells, substantially all of which have been killed, and (b) HC-HA, thereby inhibiting unwanted bone resorption.

2. The method of claim 1 , wherein the fetal support tissue is placental amniotic membrane (PAM), umbilical cord amniotic membrane (UCAM), placenta, umbilical cord, chorion, amnion-chorion, or any combinations thereof.

3. The method of claim 1 , wherein the fetal support tissue is frozen or previously frozen.

4. The method of claim 1 , wherein the fetal support tissue is a sheet, powder, or homogenate.

5. The method of claim 1 , wherein the fetal support tissue is cryopreserved, lyophilized, terminally sterilized, or a combination thereof.

6. The method of claim 1 , wherein contacting a joint characterized by unwanted bone resorption with the fetal support tissue comprises injecting the fetal support tissue into the joint.

7. The method of claim 1 , wherein contacting a bone or joint characterized by unwanted bone resorption with the fetal support tissue comprises contacting the bone or joint with a medical device comprising the fetal support tissue.

8. The method of claim 1 , wherein the medical device is a patch, implant, orthopaedic prosthesis, or bone stent.

9. The method of claim 1 , wherein contacting a bone or joint characterized by unwanted bone resorption with the fetal support tissue comprises wrapping a fetal support tissue sheet around the bone or joint.

10. The method of claim 1 , wherein osteogenesis is promoted.

11. The method of claim 1 , wherein the unwanted bone resorption is associated with arthritis, osteoporosis, a bone tumor, Paget's Disease, alveolar bone degradation, or any combination thereof.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2026
From: BIOTISSUE HOLDINGS INC.
To: BLUE TECH INDUSTRIES, INC.
Reel/Frame 073754/0181 →
RELEASE OF SECURITY INTEREST Recorded Jan 22, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: BIOTISSUE HOLDINGS INC.; BIOTISSUE OCULAR INC.; BIOTISSUE SURGICAL INC.
Reel/Frame 073556/0101 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FUNDING IV TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0200 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FINANCIAL TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0165 →
SECURITY INTEREST Recorded Jun 7, 2024
From: BIOTISSUE HOLDINGS INC.; BIOTISSUE OCULAR INC.; BIOTISSUE SURGICAL INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 067666/0235 →
CHANGE OF NAME Recorded May 22, 2023
From: TISSUETECH, INC.
To: BIOTISSUE HOLDINGS INC.
Reel/Frame 063713/0329 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - TERM LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060116/0413 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - REVOLVING LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 060116/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2013
From: TSENG, SCHEFFER; TAN, EK KIA; HE, HUA
To: TISSUETECH, INC.
Reel/Frame 031851/0152 →
Continuity (2)
Provisional Application 61480281 · Apr 28, 2011
Related Publication 20140112998A1 · Apr 24, 2014